Maximize Your Impact at FENS Forum 2026
FENS Forum 2026, scheduled for July 4–8, 2026, in Barcelona, Catalunya, Spain, is Europe’s largest neuroscience meeting and one of the most important global events for advancing brain research. The forum brings together thousands of leading scientists, clinical researchers, academic decision-makers, and senior-level professionals working across neural health, therapeutics, cognitive science, and biotechnology initiatives.
Attendees are deeply involved in influencing research direction, clinical collaborations, technology adoption, and institutional funding priorities. The event serves as a critical platform for establishing partnerships between research centers, biotech companies, pharmaceutical leaders, and academic institutions. With early access to the enriched attendee list from Vendelux, your team can identify the researchers, senior clinicians, procurement heads, and program leads who will be driving real decisions before and after the forum begins.
How Sales, Marketing and Revops Teams Can Use This Attendee List
FENS Forum supports not just scientific knowledge sharing, but meaningful collaboration between private sector innovation and academic or clinical research. The enriched attendee list gives teams the opportunity to segment contacts by neuroscience specialty, institutional affiliation, or funding access, enabling fully relevant outreach.
This data lets you go beyond generic promotion—use specific attendee insights to open doors into lab procurement, university-industry pilot programs, and early research funding partners. Early outreach to senior researchers and program heads helps teams book strategic meetings ahead of time, making your in-person presence more effective and focused.
With updated roles, channels, and verified insights, this list helps you follow up after the event with personalized proposals, study support, or technical enablement that aligns with what was discussed on-site. Teams looking to understand how to get more meetings at a conference like this can use the Vendelux data to track who holds budget influence, what their organizational priorities are, and which collaboration stage they’re in.
Timing Is Everything
FENS Forum 2026 takes place July 4–8, 2026. Outreach should begin several months in advance to target institutional leads while their networking calendars are open and program planning is still being finalized. Vendelux offers the visibility you need to identify strategic contacts early, enabling better preparation and more meaningful meetings.
By aligning your sales and marketing efforts with the attendee list as soon as it becomes available, your organization can ensure you’re not one of many reaching out too late. Timely engagement helps drive higher conversion both on-site and in quarterly cycles after the event.
What’s Included in the FENS Forum 2026 Attendee List?
Vendelux provides visibility into executives and researchers expected to attend FENS Forum 2026 through a combination of organizer data and predictive insights. Clients can upload a list of strategic accounts to find overlap within the attendee list. The enriched attendee list includes first and last names, job titles, company or institution names, company websites, city, state, and country details, LinkedIn profiles, verified email addresses, and phone numbers when available.
Where Is FENS Forum 2026?
The event will take place in Barcelona, Catalunya, Spain. The exact venue is to be announced.
When Is FENS Forum 2026?
FENS Forum 2026 is scheduled for July 4–8, 2026.
What Type Of Event Is FENS Forum 2026?
FENS Forum is a global neuroscience conference, focusing on advanced research, therapeutic innovation, and institutional collaboration across brain sciences. The event features large-scale scientific symposia, keynote sessions by renowned neuroscientists, interactive panels, and extensive networking opportunities connecting academia, pharma, hospitals, and industry players.
How Many People Attend FENS Forum 2026?
FENS Forum 2026 is expected to welcome over 7,000 attendees from more than 75 countries. The audience includes senior researchers, postdoctoral scientists, funding agencies, policy leaders, and executives from biotech and pharmaceutical companies.
